Imiquimod (INN) is a prescription medication that acts as an immune response modifier. It is marketed by Meda AB Graceway Pharmaceuticals and iNova Pharmaceuticals under the trade names Aldara and Zyclara and by Mochida as Beselna. It is also referred to as R-837. Due to the bankruptcy of Graceway in 2011 Medicis Pharmaceutical Corporation is the current owner of these products.
This page contains content from the copyrighted Wikipedia article "Imiquimod"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
